Destination Wealth Management Pfizer Inc Transaction History

Destination Wealth Management

$3 Billion
Q2 2024

A detailed history of Destination Wealth Management transactions in Pfizer Inc stock. As of the latest transaction made, Destination Wealth Management holds 665,021 shares of PFE stock, worth $19.3 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

665,021

Previous 630,746 5.43%

Holding current value

$19.3 Million

Previous $17.5 Million 6.31%

% of portfolio

0.62%

Previous 0.59%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 24, 2024	BUY	$25.26 - $29.6 $865,786 - $1.01 Million	34,275 Added 5.43%	665,021 $18.6 Million
Q1 2024 May 14, 2024	BUY	$25.89 - $29.73 $2.8 Million - $3.21 Million	108,068 Added 20.68%	630,746 $17.5 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $2.06 Million - $2.67 Million	-78,657 Reduced 13.08%	522,678 $15 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $732,165 - $855,828	22,816 Added 3.94%	601,335 $19.9 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $445,215 - $515,103	12,326 Added 2.18%	578,519 $21.2 Million
Q1 2023 May 05, 2023	BUY	$39.39 - $51.28 $480,833 - $625,974	12,207 Added 2.2%	566,193 $23.1 Million
Q4 2022 Feb 10, 2023	SELL	$41.75 - $54.5 $526,425 - $687,190	-12,609 Reduced 2.23%	553,986 $28.4 Million
Q3 2022 Nov 10, 2022	SELL	$43.76 - $53.42 $75,617 - $92,309	-1,728 Reduced 0.3%	566,595 $24.8 Million
Q2 2022 Jul 29, 2022	SELL	$46.53 - $55.17 $243,770 - $289,035	-5,239 Reduced 0.91%	568,323 $29.8 Million
Q1 2022 May 12, 2022	SELL	$45.75 - $56.69 $428,540 - $531,015	-9,367 Reduced 1.61%	573,562 $29.7 Million
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $9,007 - $13,352	-218 Reduced 0.04%	582,929 $34.4 Million
Q3 2021 Oct 25, 2021	SELL	$39.25 - $50.42 $22,843 - $29,344	-582 Reduced 0.1%	583,147 $25.1 Million
Q2 2021 Aug 13, 2021	BUY	$35.91 - $40.68 $596,213 - $675,410	16,603 Added 2.93%	583,729 $22.9 Million
Q1 2021 May 05, 2021	BUY	$33.49 - $37.77 $1.08 Million - $1.22 Million	32,374 Added 6.05%	567,126 $20.5 Million
Q4 2020 Feb 11, 2021	BUY	$33.47 - $42.56 $207,547 - $263,914	6,201 Added 1.17%	534,752 $19.7 Million
Q3 2020 Nov 12, 2020	BUY	$31.75 - $37.25 $198,437 - $232,812	6,250 Added 1.2%	528,551 $19.4 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $232,195 - $281,686	7,709 Added 1.5%	522,301 $17.1 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $211,104 - $301,622	7,810 Added 1.54%	514,592 $16.8 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $515,296 - $584,796	15,653 Added 3.19%	506,782 $19.9 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $796,654 - $1.03 Million	24,520 Added 5.25%	491,129 $17.6 Million
Q2 2019 Jul 19, 2019	SELL	$36.98 - $41.52 $285,966 - $321,074	-7,733 Reduced 1.63%	466,609 $20.2 Million
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $615,300 - $676,009	-16,408 Reduced 3.34%	474,342 $20.1 Million
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $459,024 - $523,337	-11,932 Reduced 2.37%	490,750 $21.4 Million
Q3 2018 Nov 07, 2018	BUY	$34.47 - $41.81 $70,422 - $85,417	2,043 Added 0.41%	502,682 $22.2 Million
Q2 2018 Jul 31, 2018	BUY	$32.98 - $35.16 $16.5 Million - $17.6 Million	500,587 Added 962667.31%	500,639 $18.2 Million
Q1 2018 Apr 05, 2018	SELL	$31.91 - $37.02 $4.73 Million - $5.49 Million	-148,190 Reduced 99.96%	52 $1,000
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $76,730 - $81,414	2,307 Added 1.58%	148,242 $5.37 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $3,410 - $3,756	110 Added 0.08%	145,935 $5.21 Million
Q2 2017 Aug 11, 2017	BUY	N/A	145,825	145,825 $4.9 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Destination Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Destination Wealth Management with notifications on news.

Account

Destination Wealth Management Pfizer Inc Transaction History